Section 5. Further expanding the criteria for hcc in living donor liver transplantation: When not to transplant: Snuh experience

Transplantation

Volumn 97, Issue 8, 2014, Pages S20-S23

  Lee, Kwang Woong ^a   Yi, Nam Joon ^a   Suh, Kyung Suk ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Advanced hepatocellular carcinoma; Expanded criteria; Hepatocellular carcinoma

Indexed keywords

ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; LONG TERM SURVIVAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED STATES; BLOOD; DECISION SUPPORT SYSTEM; DISEASE FREE SURVIVAL; DRUG CONTRAINDICATION; LIVER TUMOR; METASTASIS; METHODOLOGY; MORTALITY; MULTIPLE CANCER; PATHOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; RISK FACTOR; SOUTH KOREA; TIME; TUMOR INVASION; TUMOR RECURRENCE; TUMOR VOLUME; UNIVERSITY HOSPITAL;

AFP PROTEIN, HUMAN; ALPHA FETOPROTEIN;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DECISION SUPPORT TECHNIQUES; DISEASE-FREE SURVIVAL; HOSPITALS, UNIVERSITY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, MULTIPLE PRIMARY; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; REPUBLIC OF KOREA; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 85047288873     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000446267.19148.21     Document Type: Article

References (11)

1. Yi NJ, Suh KS, Kim T, et al. Current role of surgery in treatment of early stage hepatocellular carcinoma: resection versus liver transplantation. Oncology 2008; 75(Suppl 1): 124.
2. Poon RT, Fan ST, Lo CM, et al. Long-Term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002; 235: 373.
3. Adam R, Azoulay D, Castaing D, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: A reasonable strategy? Ann Surg 2003; 238: 508.
4. Park MS, Lee KW, Suh SW, et al. Liver Transplantation Versus Liver Resection for the Treatment of Hepatocellular Carcinoma. Liver Transpl 2013; 19(Suppl 1 (6)): S118.
5. Suh KS, Cho EH, Lee HW, et al. Liver transplantation for hepatocellular carcinoma in patients who do not meet the Milan criteria. Dig Dis 2007; 25: 329.
6. Yang SH, Suh KS, Lee HW, et al. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma. Surgery 2007; 141: 598.
7. Lee JW, Paeng JC, Kang KW, et al. Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma. J Nucl Med 2009; 50: 682.
8. Hong G, Suh KS, Kim HY, et al. Preoperative serum AFP level and serum PIVKA II level and 18F-FDG PET positivity of the tumor predict tumor recurrence better than Milan criteria for patients with HCC in adult-To-Adult living donor liver transplantation. Liver Transpl 2012; 18(Suppl 1): S94.
9. Elsharkawi M, Staib L, Henne-Bruns D, et al. Complete remission of postransplant lung metastases from hepatocellular carcinoma under therapy with sirolimus and mycophenolate mofetil. Transplantation 2005; 79: 855.
10. Kornberg A, Kupper B, Tannapfel A, et al. Long-Term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables. Eur J Surg Oncol 2010; 36: 275.
11. Suh KS, Hong G, Kim HY, et al. Outcome of living donor liver transplantation for patients with far advanced hepatocellular carcinoma. Liver Transpl 2012; 18(Suppl 1): S214.